Literature DB >> 27504324

A Comparative Study to Assess the Determinants and Outcomes of Sepsis Treated in Medical Wards and ICU in an Indian Teaching Hospital.

Prasanta Kumar Bhattacharya1, Debdutta Gautom2, Neena Nath3, Hiranya Saikia4.   

Abstract

INTRODUCTION: Sepsis is the primary cause of death from infection worldwide. In resource-limited countries, increasing number of sepsis is managed in non-ICU settings, in Medical Wards (MW). AIM: To compare the burden, aetiology and short term outcome of sepsis treated in MW with ICU.
MATERIALS AND METHODS: Prospective, observational, analytical study in sepsis patients in general MW and medical ICU in a tertiary care hospital. Two hundred forty five sepsis patients (MW=150, ICU=95), ≥18 years, selected randomly, were studied to compare aetiology, co-morbidities, clinical &amp; microbiological profile and short-term outcome between MW and ICU sepsis. Sepsis following surgery, trauma, those transferred to/from ICU, those with other life threatening diseases were excluded. Chi-square test/Fisher's-exact test was used for comparing ratios. A 'p-value' <0.05 was considered statistically significant.
RESULTS: Sepsis was more common in elderly males, both in MW and ICU (median age: 56.7, 59.2 years; male: female ratios = 1.34:1, 1.63:1 respectively). Frequency of presenting symptoms, co-morbidities and sources of sepsis were similar in both groups (p>0.05). Frequency of positive microbiological culture, pattern of microbial flora and antimicrobial resistance patterns were similar in both groups (p>0.05). Number of antibiotics used was significantly higher in ICU compared to MW (p<0.01); multi-organ dysfunction and mortality were significantly higher in ICU settings (55.8% vs. 38.7%, p=0.04; 48.4% vs. 32.6%, p=0.041 respectively). While sepsis and severe sepsis were significantly higher in MW (34.6% vs. 22.1 %, p=0.03; 47.3% vs. 26.3%, p<0.01 respectively), septic shock was significantly higher in ICU (51.6% vs. 18.0%, p<0.01). Mortality in both settings was highest in septic shock (55.5% and 61.2%, p>0.05) and multi-organ dysfunction (55.1% and 64.2%, p>0.05). Duration of hospital stay was significantly shorter in MW than ICU (7.3 vs. 11.0 days, p<0.01).
CONCLUSION: Our study aimed to identify determinants and outcome of sepsis in MW and compare with ICU settings. Antibiotic usage in the two settings differed: concurrent use of ≥3 antibiotics, and carbapenems &amp; linezolid usage were significantly higher in ICU compared to MW. Sepsis in MW had significantly lower incidence of multi-organ failure, lower mortality and shorter hospital stay compared to ICU.

Entities:  

Keywords:  Antibiotic resistance; Co-morbidities; Hospital stay; Mortality; Organ dysfunction; Sepsis syndromes

Year:  2016        PMID: 27504324      PMCID: PMC4963684          DOI: 10.7860/JCDR/2016/18114.7949

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  20 in total

1.  Benchmarking the incidence and mortality of severe sepsis in the United States.

Authors:  David F Gaieski; J Matthew Edwards; Michael J Kallan; Brendan G Carr
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

2.  Epidemiology and outcomes in patients with severe sepsis admitted to the hospital wards.

Authors:  Stacey-Ann Whittaker; Barry D Fuchs; David F Gaieski; Jason D Christie; Munish Goyal; Nuala J Meyer; Craig Kean; Dylan S Small; Scarlett L Bellamy; Mark E Mikkelsen
Journal:  J Crit Care       Date:  2014-07-22       Impact factor: 3.425

3.  Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department.

Authors:  Alan C Heffner; James M Horton; Michael R Marchick; Alan E Jones
Journal:  Clin Infect Dis       Date:  2010-03-15       Impact factor: 9.079

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

5.  Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study.

Authors:  Filippo Mearelli; Nicola Fiotti; Nicola Altamura; Michela Zanetti; Giovanni Fernandes; Ismet Burekovic; Alessandro Occhipinti; Daniele Orso; Carlo Giansante; Chiara Casarsa; Gianni Biolo
Journal:  Intern Emerg Med       Date:  2013-12-22       Impact factor: 3.397

6.  Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study.

Authors:  Mitchell M Levy; Antonio Artigas; Gary S Phillips; Andrew Rhodes; Richard Beale; Tiffany Osborn; Jean-Louis Vincent; Sean Townsend; Stanley Lemeshow; R Phillip Dellinger
Journal:  Lancet Infect Dis       Date:  2012-10-26       Impact factor: 25.071

7.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

Authors:  C Brun-Buisson; F Doyon; J Carlet; P Dellamonica; F Gouin; A Lepoutre; J C Mercier; G Offenstadt; B Régnier
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

8.  Sepsis and multiorgan dysfunction. Abstracts of the 6th International Congress, Weimar Sepsis Update 2013-Consensus and Controversies. September 4-6, 2013. Weimer, Germany.

Authors: 
Journal:  Infection       Date:  2013-08       Impact factor: 3.553

9.  Surviving sepsis: going beyond the guidelines.

Authors:  Paul E Marik
Journal:  Ann Intensive Care       Date:  2011-06-07       Impact factor: 6.925

10.  Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality.

Authors:  Issrah Jawad; Ivana Lukšić; Snorri Bjorn Rafnsson
Journal:  J Glob Health       Date:  2012-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.